Results 41 to 50 of about 869 (178)

PB2227 COMPASSIONATE USE OF ROPEGINTERFERON TO TREAT MYELOPROLIFERATIVE NEOPLASMS IN TAIWAN

HemaSphere, Volume 3, Issue S1, Page 999, June 2019., 2019
Background: There is a high unmet medical need for therapeutic options for patients suffering from myeloproliferative neoplasms (MPN), who have failed or are not eligible to available treatment options. Ropeginterferon‐alfa‐2b (P1101) is a novel, third generation pegylated interferon‐alfa, recently approved by EMA to treat polycythemia vera (PV ...
C.‐C. Chen, M.‐C. Kuo, Y. ‐.‐J. Su, C.‐E. Huang, C.‐C. Hsu, Y.‐Y. Wu, Y.‐J. Chen, L.‐Y. Shih   +7 more
wiley   +1 more source

PB2229 DISEASE CHARACTERISTICS AND RESPONSE TO TREATMENT OF PATIENTS WITH MYELOFIBROSIS:A MULTICENTRE DESCRIPTIVE, RETROSPECTIVE STUDY FROM SRI LANKA

HemaSphere, Volume 3, Issue S1, Page 999, June 2019., 2019
Background: Myelofibrosis (MF)is a BCR/ABL negative, myeloproliferative neoplasm. The manifestations of MF include constitutional symptoms, splenomegaly, anaemia and other cytopenias. Most of the patients are elderly with multiple comorbidities and cannot undergo, allogeneic stem cell transplantation.
D. Moratuwagama, Y. Costa, S. Senanayake, H. Williams, B. Jayaratne B, V. Rathnamalala, N. Ranasinghe, L. Gooneratne, H. Goonesekara, D. Gunewardena, I. Wijesiriwardene, C. Kulathilake C, A. Jayawardene A, J. D. Silva, I. Dharmasena, N. Perera, N. Mendis, P. Vitharana, R. Jayathunga, H. Gunasekara, L. Basnayake, Y. Samaraweera, T. Sooriyakumar, D. Dissanayake, W. Vidyaratne, K. Jayaratne, H. Alwis, R. Wijeratne, A. Attanayake, S. Athawuda, R. Pullaperuma, B. Somarathna, S. Yoganathan, L. Senerath, V. Gunawardena, B. Balasooriya, D. Epa, B. Fernandopulle, C. Moonesinhge   +38 more
wiley   +1 more source

PB2230 SYSTEMIC MASTOCYTOSIS WITH ASSOCIATED HEMATOLOGIC NEOPLASM, EVOLVING TO SIMULTANEOUS CD33 POSITIVE MAST CELL LEUKEMIA AND ACUTE MYELOID LEUKEMIA, TREATED WITH GEMTUZUMAB‐OZOGAMICIN

HemaSphere, Volume 3, Issue S1, Page 999-1000, June 2019., 2019
Background: Mast cell leukemia (MCL) is an extremely rare subtype of systemic mastocytosis (SM), with only 50 cases described so far. It confers an extremely bad prognosis, with an overall survival of few months. Aims: To describe an extremely rare case of MCL and AML treated with Gemtuzumab‐Ozogamicin (GO).
P. López‐Pereira, Á. Figuera, I. Ormazábal, J. Cornago, E. Sola, M. Quesada, A. Savchuk, V. Lizandro, A. de la Fuente, R. Ayala, I. Álvarez‐Twose, J. L. Steegmann   +11 more
wiley   +1 more source

Urticaria asociada a COVID-19 en pacientes alérgicos. Serie de casos

Revista Alergia México, 2021
Introducción: En diciembre de 2019 fue identificado un nuevo coronavirus como agente causal de la enfermedad por coronavirus del 2019 con un amplio espectro clínico, desde casos asintomáticos hasta críticos y fatales.
Ricardo Cardona, Catalina López
doaj   +1 more source

Mastocitosis cutáneas : a propósito de tres casos de urticaria pigmentosa [PDF]

, 2015
Las mastocitosis son un grupo de enfermedades que tienen en común la proliferación y acumulación de mastocitos en la piel y tejidos extracutáneos. El 65% de ellas se inicia en la infancia.
Innocenti, Carolina, Merino, Avelina, Parra, Viviana Gladys, Suso, Leticia   +3 more
core  

Bone and Cytokine Markers Associated With Bone Disease in Systemic Mastocytosis [PDF]

, 2023
Background Mastocytosis encompasses a heterogeneous group of diseases characterized by tissue accumulation of clonal mast cells, which frequently includes bone involvement. Several cytokines have been shown to play a role in the pathogenesis of bone mass
Caldas, C, Cavaleiro Rufo, J, García-Montero, A, Henriques, AF, Jara-Acevedo, M, Matito, A, Mayado, A, Moreira, A, Muñoz-González, JI, Rama, TA, Sanchez-Muñoz, L, Álvarez-Twose, I, Órfão, A   +12 more
core   +2 more sources

C‐Kit Expression, Angiogenesis, and Grading in Canine Mast Cell Tumour: A Unique Model to Study C‐Kit Driven Human Malignancies

BioMed Research International, Volume 2014, Issue 1, 2014., 2014
Canine cutaneous mast cell tumour (CMCT) is a c‐Kit driven tumour sharing similar c‐Kit aberrations found in human gastrointestinal stromal tumour. CMCT is classified into three forms: well‐ (G1), intermediately (G2) (more benign diseases), and poorly (G3) differentiated (malignant) forms.
Rosa Patruno, Ilaria Marech, Nicola Zizzo, Michele Ammendola, Patrizia Nardulli, Claudia Gadaleta, Marcello Introna, Gennaro Capriuolo, Rosa Angela Rubini, Domenico Ribatti, Cosmo Damiano Gadaleta, Girolamo Ranieri, Krzysztof Okoń   +12 more
wiley   +1 more source

Manejo anestésico de paciente con mastocitosis cutánea [PDF]

Revista Chilena de Anestesia, 2021
Álvaro Pérez Fernández-Escandón
doaj   +1 more source

Functional proteomics approaches for high throuput determination of CKIT and small molecules [PDF]

, 2011
Comunicaciones a ...
Bartolomé-Casado, Raquel, Escribano, L., Fuentes, Manuel, González-González, María, Jara-Acevedo, María, Jara-Acevedo, Ricardo, Labaer, Joshua, Orfao, Alberto   +7 more
core  

La redacción del título en los artículos médicos [PDF]

, 2009
En este trabajo, presentamos una selección de anomalías frecuentes en la construcción de títulos que identifican la producción de relatos orientados hacia el avance de la ciencia, en literatura médica.
Uribarri, Iris
core